
Robra Injection
Marketer
Aadi Health Care
Salt Composition
Rabeprazole (20mg)
Overview Robra Injection
AcidGard injection rapidly reduces stomach acid production. It treats acid-related gastrointestinal disorders, including acid reflux, indigestion, peptic ulcers, and other conditions stemming from excessive stomach acid. Providing swift relief from acidity, AcidGard is also used prophylactically against stress ulcers in critically ill patients and pre-anesthesia to mitigate aspiration risks. A proton pump inhibitor (PPI), this intravenous medication is administered by a healthcare professional only when deemed superior to oral forms. Dosage and treatment duration are determined by your doctor based on your condition and response, requiring adherence to the prescribed regimen even with rapid symptom resolution. Optimizing treatment involves consuming smaller, more frequent meals, while avoiding caffeinated beverages, spicy foods, and fatty meals. Common, generally mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects warrant medical attention. Prolonged use (over one year) may increase the risk of bone fractures, particularly at higher doses. Discuss bone loss prevention strategies, like calcium and vitamin D supplementation, with your doctor. Hypomagnesemia (low magnesium) can occur after three months or more of use, potentially causing fatigue, confusion, dizziness, muscle spasms, and arrhythmias. Your doctor may monitor your magnesium levels. AcidGard is contraindicated in individuals with severe liver disease, those taking HIV medications, those with a history of similar medication allergies, or pre-existing osteoporosis. Pregnant or breastfeeding individuals should consult their doctor. Alcohol should be avoided due to its acid-stimulating effect. Refrain from operating machinery or driving if dizziness or drowsiness occurs.
Uses of Robra Injection
Management of acid indigestion and peptic ulcers.
Major Benefits of Robra Injection:
This medication will be administered by your physician or their qualified staff; self-medication is strictly prohibited.
Common Side effects of Robra Injection:
- Nausea
- Vomiting
- Headache
- Dizziness
- Flatulence
- Diarrhea
- Stomach pain
- Thrombophlebitis
How to use Robra Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Robra Injection works:
Gastric acid secretion is diminished by Robra Injection, a proton pump inhibitor (PPI), thus alleviating heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Use of Robra Injection with alcohol requires careful consideration. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Robra Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. Your physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Robra Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Driving ability may be affected by Robra Injection; however, this effect is currently undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Robra Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCAUTION
Administering Robra Injection requires careful consideration in individuals with advanced hepatic impairment. Dosage modification for Robra Injection may be necessary. Physician consultation is advised.
What if you forget to take Robra Injection :
Should you forget a scheduled dose of Robra Injection, seek your physician's advice.
Facts to Know About Robra Injection
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | Gastric acid suppressants |
